Moreover, Ly6C+CD8+ population from EMT6 tumor-primed mice showed much higher effector activity compared with Ly6C−CD8+ population, suggesting that this CD8+ T-cell population involved in eradication of DTCs. This evidence concerns the gene CD8A and neoplasm.